New diabetes drug shows promise in early trial
NCT ID NCT06982859
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 20 times
Summary
This study tests a new medicine called retatrutide in adults with type 2 diabetes. The goal is to see if it improves how the body makes and uses insulin compared to a placebo or another diabetes drug. About 95 people will take part, and they will continue their usual diabetes medications during the study.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil Institut für Stoffwechselforschung
RECRUITINGNeuss, 41460, Germany
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.